The drug, which treats brain cancers including glioblastoma, does not have a generic alternative and can cost as much as $1,000 per capsule, the article said.
In a statement to the Journal, NextSource said it is exploring a new contract with the program and plans to participate again in the future, though it did not specify why the drug’s coverage benefits ended Jan. 1.
NextSource also told the publication that Medicare patients meeting certain income criteria have been eligible to receive the drug at no cost since January.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
